BioSpace News Archive

Business

Microbix Reports Results for Q3 Fiscal 2023

Microbix Biosystems Inc. reports results for its third quarter and YTD fiscal 2023 ended June 30, 2023 (“ Q3 ” and “ YTD ”), a period in which strong revenues were realized along with a fully-funded partnering of its drug asset Kinlytic ® urokinase (“ Kinlytic ”).

August 10, 2023
·
9 min read
Pharm Country

ProPhase Labs Announces Financial Results for the Three Months Ended June 30, 2023

ProPhase Labs, Inc., a next generation biotech, genomics, therapeutics and diagnostics company, reported its financial and operational results for the three months ended June 30, 2023.

August 10, 2023
·
26 min read
BioMidwest

On Target Laboratories Granted New Technology Add-On Payment (NTAP) for CYTALUX® (pafolacianine) injection in Ovarian and Lung Cancer Indications

On Target Laboratories, Inc. announced that the Centers for Medicare & Medicaid Services has granted a new technology add-on payment for CYTALUX for use in ovarian and lung cancer.

August 10, 2023
·
3 min read
Business

Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2023

Lipocine Inc. today announced financial results for the second quarter and six months ended June 30, 2023, and provided a corporate update.

August 10, 2023
·
11 min read
Drug Development

CymaBay Initiates IDEAL, a Phase 3 Placebo-Controlled, Randomized Study of Seladelpar in Patients with Primary Biliary Cholangitis and Incomplete Control of Alkaline Phosphatase

CymaBay Therapeutics, Inc. today announced the initiation of its 52-week, placebo-controlled, randomized, Phase 3 study.

August 10, 2023
·
5 min read
Biotech Bay

Imperative Care Unveils New Structure to Elevate Care for Patients with Vascular Diseases

Imperative Care, Inc., a medical technology company elevating care for people affected by stroke and other ischemic diseases, announced a new organizational structure designed to accelerate the company’s growth across its businesses.

August 10, 2023
·
6 min read
Business

Edgewise Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights

Edgewise Therapeutics, Inc. today reported financial results for the second quarter of 2023 and recent business highlights.

August 10, 2023
·
15 min read
Business

UroGen Pharma Reports Record JELMYTO Quarterly Sales and Recent Corporate Developments

UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced financial results for the second quarter ended June 30, 2023, and provided an overview of recent developments.

August 10, 2023
·
18 min read
Deals

Ainos Celebrates First Listing Anniversary on Nasdaq

Ainos, Inc. today announced that it is celebrating the one-year anniversary of its listing on the Nasdaq.

August 10, 2023
·
6 min read
Business

Aptevo Therapeutics Reports 2Q23 Financial Results and Provides a Business Update

Aptevo Therapeutics Inc. today reported financial results for the quarter ended June 30, 2023 and provided a business update, including duration of remission (DOR) data for its lead clinical candidate, APVO436.

August 10, 2023
·
13 min read